BRCA1 & BRCA2 Mutation Analysis is a genetic test used to identify inherited mutations in the BRCA1 and BRCA2 genes. These genes play a vital role in repairing damaged DNA. Mutations in these genes can significantly increase the risk of developing certain cancers, particularly breast, ovarian, prostate, and pancreatic cancers.
Why is this Test Recommended?
Assess hereditary cancer risk
Family history of breast or ovarian cancer
Early-onset breast cancer diagnosis
Multiple family members affected by cancer
Male breast cancer history
Personalized cancer prevention and treatment planning
Sample Required
Peripheral Blood (EDTA Blood)
Test Method
Next-Generation Sequencing (NGS)
Mutation Analysis of BRCA1 & BRCA2 Genes
Benefits of the Test
✔ Identifies inherited cancer-related mutations ✔ Helps guide preventive healthcare decisions ✔ Supports personalized treatment strategies ✔ Assists in family risk assessment and genetic counseling ✔ Enables early surveillance and risk management
Who Should Consider This Test?
Individuals with a strong family history of breast or ovarian cancer
Patients diagnosed with breast cancer at a young age
Individuals with a family history of BRCA mutations
Those seeking hereditary cancer risk evaluation
Preparation
No special preparation is required. Genetic counseling may be recommended before and after testing.
Interpretation
Positive: Pathogenic mutation detected, indicating increased hereditary cancer risk.
Negative: No clinically significant mutation detected in the tested regions.
Variant of Uncertain Significance (VUS): Genetic alteration detected with unclear clinical significance.